NCT05107362

Brief Summary

The Checkable Medical At-Home Strep A Test is a rapid chromatographic immunoassay for the qualitative detection of Group A Strep (GAS) antigens from throat swabs. The purpose of the study is to evaluate the clinical performance of the investigational device (i.e., sensitivity, specificity, NPV and PPV) when used by untrained lay persons to detect the presence of Group A Streptococcal antigens in throat swab specimens from individuals five years of age and older with signs and symptoms of pharyngitis, such as fever and sore throat.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,347

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

22 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 4, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

December 21, 2021

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 10, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2023

Completed
Last Updated

July 12, 2023

Status Verified

March 1, 2023

Enrollment Period

1.6 years

First QC Date

October 25, 2021

Last Update Submit

July 10, 2023

Conditions

Keywords

In vitro diagnostic

Outcome Measures

Primary Outcomes (1)

  • Clinical Sensitivity and Clinical Specificity

    Sensitivity is the proportion of subjects with a positive bacterial culture that are also positive in the investigational Strep A test (+). Specificity is the proportion of subjects with a negative bacterial culture that are also negative in the investigational Strep A test (-).

    1 day

Secondary Outcomes (1)

  • Negative Predictive Value

    1 day

Study Arms (1)

Symptomatic Adult and Pediatric Subjects

Untrained lay user to collect throat swab specimen and perform investigational test.

Diagnostic Test: untrained lay user performs investigational diagnostic test

Interventions

Untrained lay users (parents/guardians of pediatric subjects or friends/family members of adult subjects) collect throat swab specimens and perform the investigational diagnostic test.

Symptomatic Adult and Pediatric Subjects

Eligibility Criteria

Age5 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A total of 610 to 1,220 male and female subjects in the US, with approximately 183 subjects being strep positive, are expected to participate in the study. At least half of the subjects will be between 5 and 17 years of age and the remaining subjects will be adults 18 years of age and older.

You may qualify if:

  • Subjects seeking medical care for two or more of the following signs/symptoms of pharyngeal streptococcal infections:
  • pharyngeal pain \[with or without swallowing\],
  • tonsillar swelling with exudates,
  • pharyngeal erythema,
  • tender cervical lymphadenopathy,
  • fever.
  • Subjects who have not received antibiotic treatment within the past 14 days.
  • Subjects (or their parents/guardians) provide written informed consent/assent to participate in the study

You may not qualify if:

  • \. Lay users who are accompanying patients are unwilling/unable to collect throat swab sample from a child or adult.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (22)

Robertson Pediatrics

Beverly Hills, California, 90211, United States

Location

Angel Kids Pediatrics

Jacksonville, Florida, 32225, United States

Location

L&A Morales Health Care

Miami, Florida, 33142, United States

Location

Elite Clinical Trials

Blackfoot, Idaho, 83221, United States

Location

Waggoner Pediatrics

Clive, Iowa, 50325, United States

Location

WellNow Urgent Care and Research

Kalamazoo, Michigan, 49048, United States

Location

Axis Clinicals

Dilworth, Minnesota, 56529, United States

Location

Infinitive Bio Research

Edison, New Jersey, 08817, United States

Location

Twelve Corners Pediatrics

Rochester, New York, 14618, United States

Location

AFC Urgent Care

The Bronx, New York, 10465, United States

Location

Plains Clinical Research

Fargo, North Dakota, 58104, United States

Location

Trinity Health

Minot, North Dakota, 58701, United States

Location

WellNow Urgent Care and Research

Lorain, Ohio, 44053, United States

Location

WellNow Urgent Care and Research

Milford, Ohio, 45150, United States

Location

WellNow Urgent Care and Research

Troy, Ohio, 45373, United States

Location

AFC Urgent Care

Easley, South Carolina, 29640, United States

Location

Tribe Clinical Research

Greenville, South Carolina, 29607, United States

Location

MDFirst

Lancaster, South Carolina, 29720, United States

Location

Pediatric Associates

Houston, Texas, 77087, United States

Location

Santa Clara Family Clinic

Houston, Texas, 77087, United States

Location

Pediatric Center

Richmond, Texas, 77469, United States

Location

North Houston Internal Medicine and Pediatric Clinic

Tomball, Texas, 77375, United States

Location

MeSH Terms

Conditions

Streptococcal InfectionsPharyngitisRespiratory Tract Infections

Condition Hierarchy (Ancestors)

Gram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsPharyngeal DiseasesStomatognathic DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Marla McIntyre

    Checkable Medical

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 25, 2021

First Posted

November 4, 2021

Study Start

December 21, 2021

Primary Completion

July 10, 2023

Study Completion

July 10, 2023

Last Updated

July 12, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations